The proposed research focuses on the continued development of statistical methods for interim analyses of longitudinal studies. Previous research efforts developed a flexible group sequential procedure through an alpha spending function and applied the method to linear mixed effects models and a general class of linear rank statistics which are often used in the analysis of repeated measurement studies. We specifically want to investigate further the application of interim analyses for linear mixed effects models and for repeated categorical methods. The alpha spending function requires an estimate of the information fraction, as do all group sequential methods. An appealing estimate is the fraction of total Fisher information. For the linear mixed effects model, this estimate of information fraction is more complex than for comparison of proportions of means. We have completed some preliminary work (See Lee and DeMets, 1993) but more work is required before this aspect is totally resolved. In addition to the information fraction, we also want to evaluate the bias in the estimate of rate of change for trials which terminate early. This issue has been addressed for proportions and means but not for this method. This issue is especially of concern for extrapolating results to health care policy resulting from such trials. . We also have proposed developing methods for specific repeated categorical measures and considering issues of robustness, information fraction, and estimation bias, paralleling our efforts for the linear mixed effects model. Finally, we propose some enhancements for our software package for the flexible alpha spending function approach. We also plan to draft a clinicians handbook as a nontechnical introduction to data monitoring, including discussion of the alpha spending function, as well as many examples from completed trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA018332-19
Application #
3164926
Study Section
Special Emphasis Panel (ZRG7-SSS-1 (05))
Project Start
1978-07-01
Project End
1996-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
19
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Chen, Y H Joshua; DeMets, David L; Lan, K K Gordon (2004) Increasing the sample size when the unblinded interim result is promising. Stat Med 23:1023-38
Fleming, T R; DeMets, D L (1996) Surrogate end points in clinical trials: are we being misled? Ann Intern Med 125:605-13
Lindstrom, M J (1995) Self-modelling with random shift and scale parameters and a free-knot spline shape function. Stat Med 14:2009-21
Lee, J W; DeMets, D L (1995) Group sequential comparison of changes: ad-hoc versus more exact method. Biometrics 51:21-30
Lindstrom, M J; Kunugi, K A; Kinsella, T J (1993) Global comparison of radiation and chemotherapy dose-response curves with a test for interaction. Radiat Res 135:269-77
Kim, K; Demets, D L (1992) Sample size determination for group sequential clinical trials with immediate response. Stat Med 11:1391-9
Palta, M; Yao, T J (1991) Analysis of longitudinal data with unmeasured confounders. Biometrics 47:1355-69
Lindstrom, M L; Bates, D M (1990) Nonlinear mixed effects models for repeated measures data. Biometrics 46:673-87
Lan, K K; DeMets, D L (1989) Changing frequency of interim analysis in sequential monitoring. Biometrics 45:1017-20
Storer, B E (1989) Design and analysis of phase I clinical trials. Biometrics 45:925-37

Showing the most recent 10 out of 17 publications